1 / 25

Preventing Stroke in Patients Undergoing Cardioversion

Preventing Stroke in Patients Undergoing Cardioversion. Anticoagulation in Patients With AF. Other Post-hoc Analyses of NOAC Therapy in Patients Undergoing Cardioversion. X-VeRT Baseline Demographics. X-VeRT Exclusion Criteria. X-VeRT Design. X-VeRT Design. X-VeRT Exclusion Criteria.

porter-bruce
Download Presentation

Preventing Stroke in Patients Undergoing Cardioversion

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Preventing Stroke in Patients Undergoing Cardioversion

  2. Anticoagulation in Patients With AF

  3. Other Post-hoc Analyses of NOAC Therapy in Patients Undergoing Cardioversion

  4. X-VeRTBaseline Demographics

  5. X-VeRT Exclusion Criteria

  6. X-VeRT Design

  7. X-VeRT Design

  8. X-VeRT Exclusion Criteria

  9. X-VeRT Design

  10. X-VeRT Primary Efficacy

  11. X-VeRTPrimary Efficacy Components

  12. X-VeRT Primary Efficacy

  13. X-VeRT Safety Outcomes

  14. X-VeRT Summary of Results

  15. X-VeRT Summary of Results

  16. X-VeRT Study Limitations

  17. Treatment of Very Early Onset AF

  18. Conclusions

  19. Abbreviations

  20. Abbreviations (cont)

  21. References

  22. References (cont)

  23. References (cont)

More Related